201 related articles for article (PubMed ID: 22209977)
1. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.
Bai H; Cao Z; Deng C; Zhou L; Wang C
J Cancer Res Clin Oncol; 2012 Apr; 138(4):595-602. PubMed ID: 22209977
[TBL] [Abstract][Full Text] [Related]
2. Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis.
Li Y; Zhu X; Gu J; Hu H; Dong D; Yao J; Lin C; Fei J
Hematology; 2010 Aug; 15(4):215-21. PubMed ID: 20670480
[TBL] [Abstract][Full Text] [Related]
3. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
4. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
Wang JJ; Yu JP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
[TBL] [Abstract][Full Text] [Related]
5. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
Zhu Y; Wu J; Li S; Ma R; Cao H; Ji M; Jing C; Tang J
Cell Physiol Biochem; 2013; 32(5):1225-37. PubMed ID: 24335172
[TBL] [Abstract][Full Text] [Related]
6. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
7. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
[TBL] [Abstract][Full Text] [Related]
8. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
Li H; Hui L; Xu W
Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):269-77. PubMed ID: 22285729
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
10. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells.
Hu N; Chen L; Wang C; Zhao H
Biomed Pharmacother; 2019 Apr; 112():108720. PubMed ID: 30970520
[TBL] [Abstract][Full Text] [Related]
11. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
Li DL; Lu LH; Chen YY; Lin ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
[TBL] [Abstract][Full Text] [Related]
12. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.
Gariboldi MB; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E
Int J Oncol; 2001 Jun; 18(6):1245-9. PubMed ID: 11351258
[TBL] [Abstract][Full Text] [Related]
14. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
15. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2.
Wang XF; Shi ZM; Wang XR; Cao L; Wang YY; Zhang JX; Yin Y; Luo H; Kang CS; Liu N; Jiang T; You YP
J Cancer Res Clin Oncol; 2012 Apr; 138(4):573-84. PubMed ID: 22207524
[TBL] [Abstract][Full Text] [Related]
16. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell.
Jianwei Z; Fan L; Xiancheng L; Enzhong B; Shuai L; Can L
Tumour Biol; 2013 Dec; 34(6):3331-7. PubMed ID: 23740615
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA small nucleolar RNA host gene 1 alleviates the progression of epilepsy by regulating the miR-181a/BCL-2 axis in vitro.
Hu C; Wang S; Liu L
Life Sci; 2021 Feb; 267():118935. PubMed ID: 33359246
[TBL] [Abstract][Full Text] [Related]
19. MiR-98 promotes chondrocyte apoptosis by decreasing Bcl-2 expression in a rat model of osteoarthritis.
Wang J; Chen L; Jin S; Lin J; Zheng H; Zhang H; Fan H; He F; Ma S; Li Q
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):923-929. PubMed ID: 27590063
[TBL] [Abstract][Full Text] [Related]
20. Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.
Nishi R; Yamauchi T; Negoro E; Takemura H; Ueda T
Cancer Sci; 2013 Apr; 104(4):502-7. PubMed ID: 23320492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
